Social Medical Progression of Coronary Heart Disease With Associated Psychosocial Comorbidity -Interval Rehabilitation. (SINKO)
|ClinicalTrials.gov Identifier: NCT01589536|
Recruitment Status : Unknown
Verified April 2012 by Clinic Roderbirken.
Recruitment status was: Recruiting
First Posted : May 2, 2012
Last Update Posted : May 2, 2012
|Condition or disease||Intervention/treatment|
|Cardiovascular Events||Other: interval-rehabilitation|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||480 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Improvement of the Social Medical Progression of Coronary Heart Disease With Associated Psychosocial Comorbidity by the Use of Interval Rehabilitation.|
|Study Start Date :||October 2011|
|Estimated Primary Completion Date :||December 2015|
|Estimated Study Completion Date :||December 2016|
A Stationary psychocardiological interval-rehabilitation.
The Patients in the intervention group receive a Stationary psychocardiological interval-rehabilitation.The Interval rehabilitation is divided into individual psychological therapy with focus of Behavior therapy and relaxation therapy.
No Intervention: controlgroup
The Patients in the control group receive a personal recommendation concerning psychotherapy outpatient counseling and therapy services at home and take therapeutic help.
- Improvement of the social medical progression of coronary heart disease with associated psychosocial comorbidity by the use of interval rehabilitaion [ Time Frame: 24 months after including study ]Reducing the rate of disability pension of 18%of 9% by interval-rehabilitation with aftercare.
- Improvement of the social medical progression of coronary heart disease with associated psychosocial comorbidity by the use of interval rehabilitaion [ Time Frame: 24 months after including study ]Reduction of cardiovascular events, including deaths Improving the risk profile Improvement of health-related quality of life Improvement of mental comorbidity
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01589536
|Leichlingen, NRW, Germany, 42799|
|Contact: Sarah Neuhaeuser :+ 49 (2175) 82 - 3352 email@example.com|
|Contact: Wolfgang Mayer-Berger, Dr. med. +49 (2175) 82-4010 firstname.lastname@example.org|
|Principal Investigator: Wolfgang Mayer-Berger, Dr.med.|
|Principal Investigator:||Wolfgang Mayer-Berger, MD||Clinic Roderbirken|